Haddadin Yezan Munther has filed 9 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 95969 shares of Outlook Therapeutics, Inc. ($OTLK) on October 03, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 3, 2025 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Director | A | Stock Option (Right to Buy) | 95969 | $0.00 | 95,969.0000 | 34,796,120 | 9999.99% | 0.28% |
| Oct. 1, 2025 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Director | A | Stock Option (Right to Buy) | 286734 | $0.00 | 286,734.0000 | 34,796,120 | 9999.99% | 0.82% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Not found | A | Stock Option (Right to Buy) | 132293 | $0.00 | 132,293.0000 | 18,548,813 | 9999.99% | 0.71% |
| Oct. 3, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Not found | A | Stock Option (Right to Buy) | 19771 | $0.00 | 19,771.0000 | 18,548,813 | 9999.99% | 0.11% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Not found | A | Stock Option (Right to Buy) | 56636 | $0.00 | 56,636.0000 | 18,548,813 | 9999.99% | 0.31% |
| March 28, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Not found | P | Common Stock | 1882 | $11.82 | 5,048.7112 | 13,012,833 | 59.42% | 0.01% |
| March 7, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Not found | A | Stock Option (Right to Buy) | 94441 | $0.00 | 94,441.0000 | 13,012,833 | 9999.99% | 0.73% |
| Oct. 4, 2023 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Director | A | Stock Option (Right to Buy) | 358337 | $0.00 | 358,337.0000 | 12,508,817 | 9999.99% | 2.86% |
| March 29, 2023 | Outlook Therapeutics, Inc. | $OTLK | Haddadin Yezan Munther | Director | A | Stock Option (Right to Buy) | 41065 | $0.00 | 41,065.0000 | 227,410,533 | 9999.99% | 0.02% |